Trifluoromethanesulfonic Acid

Trifluoromethanesulfonic Acid

SCHEMBL318175

CCCCCCCCCCCCn1cc[n+](C)c1.O=S(=O)([O-])C(F)(F)F

nearest known ligand 0.68

Full drug profile on Sugi Atlas →

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 2/20 0.68
HSP90AA1 P07900 2/20 0.68
KMT2A Q03164 2/20 0.68
SMN1; SMN2 Q16637 2/20 0.68
APAF1 O14727 1/20 0.68
NPC1 O15118 1/20 0.68
PLA2G1B P04054 1/20 0.68
MAPT P10636 1/20 0.68
MAPK1 P28482 1/20 0.68
HTT P42858 1/20 0.68
RAB9A P51151 1/20 0.68
NPSR1 Q6W5P4 1/20 0.68
ATG4B Q9Y4P1 1/20 0.68
KCNH2 Q12809 7/20 0.46
FDPS P14324 10/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Trifluoromethanesulfonic Acid SCHEMBL1331129 1.00 MEN1 (0.68) MEN1HSP90AA1KMT2ASMN1; SMN2APAF1
Trifluoromethanesulfonic Acid SCHEMBL318566 1.00 MEN1 (0.68) MEN1HSP90AA1KMT2ASMN1; SMN2APAF1
Trifluoromethanesulfonic Acid SCHEMBL318764 1.00 MEN1 (0.68) MEN1HSP90AA1KMT2ASMN1; SMN2APAF1
Trifluoromethanesulfonic Acid SCHEMBL318767 1.00 MEN1 (0.68) MEN1HSP90AA1KMT2ASMN1; SMN2APAF1
Trifluoromethanesulfonic Acid SCHEMBL514445 1.00 MEN1 (0.68) MEN1HSP90AA1KMT2ASMN1; SMN2APAF1
Trifluoromethanesulfonic Acid SCHEMBL3615950 0.99 MEN1 (0.65) MEN1HSP90AA1KMT2ASMN1; SMN2APAF1
Trifluoromethanesulfonic Acid SCHEMBL1293510 0.96 MEN1 (0.62) MEN1HSP90AA1KMT2ASMN1; SMN2APAF1
Trifluoromethanesulfonic Acid SCHEMBL294105 0.94 MEN1 (0.58) MEN1HSP90AA1KMT2ASMN1; SMN2APAF1
Trifluoromethanesulfonic Acid SCHEMBL29390371 0.94 MEN1 (0.58) MEN1HSP90AA1KMT2ASMN1; SMN2APAF1
Sulfuric Acid SCHEMBL31650730 0.90 MEN1 (0.78) MEN1HSP90AA1KMT2ASMN1; SMN2APAF1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 35 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12604682-B2 Methods for patterning a semiconductor substrate using metalate salt ionic liquid crystals TOKYO ELECTRON LIMITED (JP) 2026-04-14 US disclosed
US-20250157810-A1 METHODS FOR PATTERNING A SEMICONDUCTOR SUBSTRATE USING METALATE SALT IONIC LIQUID CRYSTALS TOKYO ELECTRON LIMITED (JP) 2025-05-15 US disclosed
WO-2025101247-A1 METHODS FOR PATTERNING A SEMICONDUCTOR SUBSTRATE USING METALATE SALT IONIC LIQUID CRYSTALS TOKYO ELECTRON LIMITED (JP) 2025-05-15 WO disclosed
US-11623971-B2 Freestanding ion gel and method for preparing the same Research & Business Foundation Sungkyunkwan University (KR) 2023-04-11 US disclosed
CN-112751107-A Aluminum-air battery electrolyte and preparation method thereof 昆明理工大学 2021-05-04 CN disclosed
US-20210054127-A1 FREESTANDING ION GEL AND METHOD FOR PREPARING THE SAME Research & Business Foundation Sungkyunkwan University (KR) 2021-02-25 US disclosed
CN-112129860-A Method for determining content of coumarin components in radix angelicae pubescentis 天津中医药大学 2020-12-25 CN disclosed
EP-3080859-B1 NA BASED SECONDARY BATTERY FIELD UPGRADING USA (US) 2020-04-08 EP disclosed
US-10367226-B2 Na based secondary battery SK INNOVATION CO., LTD. (KR) 2019-07-30 US disclosed
US-9780380-B2 Current collector for battery and secondary battery comprising the same SK INNOVATION CO., LTD. (KR) 2017-10-03 US disclosed
US-20100188732-A1 MULTICOLOR DISPLAY OPTICAL COMPOSITION, OPTICAL DEVICE, AND DISPLAY METHOD OF OPTICAL DEVICE FUJI XEROX CO., LTD. (JP) 2010-07-29 US disclosed
US-7746542-B2 Multicolor display optical composition, optical device, and display method of optical device FUJI XEROX CO., LTD. (JP) 2010-06-29 US disclosed
US-7724433-B2 Composition for multi-color display material and manufacturing method thereof, and optical device and displaying method thereof FUJI XEROX CO., LTD. (JP) 2010-05-25 US disclosed
US-7538933-B2 Optical composition for multi-color display and manufacturing method thereof, and optical element and displaying method thereof FUJI XEROX CO., LTD (JP) 2009-05-26 US disclosed
US-7455903-B2 Optical materials and optical elements using the same FUJI XEROX CO., LTD. (JP) 2008-11-25 US disclosed
US-20070121193-A1 Multicolor display optical composition, optical device, and display method of optical device FUJI XEROX CO., LTD. 2007-05-31 US disclosed
US-20070115550-A1 Composition for multi-color display material and manufacturing method thereof, and optical device and displaying method thereof FUJI XEROX CO., LTD. 2007-05-24 US disclosed
US-20070008439-A1 Optical composition for multi-color display and manufacturing method thereof, and optical element and displaying method thereof FUJI XEROX CO., LTD. 2007-01-11 US disclosed
EP-1734402-A2 Optical arrangement having a periodic structural body for multi-color display and manufacturing method thereof, and optical element and displaying method thereof FUJI XEROX CO., LTD. (JP) 2006-12-20 EP disclosed
US-20060121285-A1 Optical materials and optical elements using the same FUJI XEROX CO., LTD. 2006-06-08 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12604682-B2 Methods for patterning a semiconductor substrate using metalate salt ionic liquid crystals SDC1, SDC2, SDC4 MEN1 2838/4885HSP90AA1 4448/4885KMT2A 3355/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.